• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症相关成纤维细胞与前列腺癌干细胞:相互作用机制及其对疾病进展的影响。

Cancer-associated fibroblasts and prostate cancer stem cells: crosstalk mechanisms and implications for disease progression.

作者信息

Chen Haoran, Fang Suping, Zhu Xudong, Liu Hao

机构信息

Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

出版信息

Front Cell Dev Biol. 2024 Jul 18;12:1412337. doi: 10.3389/fcell.2024.1412337. eCollection 2024.

DOI:10.3389/fcell.2024.1412337
PMID:39092186
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11291335/
Abstract

The functional heterogeneity and ecological niche of prostate cancer stem cells (PCSCs), which are major drivers of prostate cancer development and treatment resistance, have attracted considerable research attention. Cancer-associated fibroblasts (CAFs), which are crucial components of the tumor microenvironment (TME), substantially affect PCSC stemness. Additionally, CAFs promote PCSC growth and survival by releasing signaling molecules and modifying the surrounding environment. Conversely, PCSCs may affect the characteristics and behavior of CAFs by producing various molecules. This crosstalk mechanism is potentially crucial for prostate cancer progression and the development of treatment resistance. Using organoids to model the TME enables an in-depth study of CAF-PCSC interactions, providing a valuable preclinical tool to accurately evaluate potential target genes and design novel treatment strategies for prostate cancer. The objective of this review is to discuss the current research on the multilevel and multitarget regulatory mechanisms underlying CAF-PCSC interactions and crosstalk, aiming to inform therapeutic approaches that address challenges in prostate cancer treatment.

摘要

前列腺癌干细胞(PCSCs)是前列腺癌发展和治疗耐药性的主要驱动因素,其功能异质性和生态位已引起了相当多的研究关注。癌症相关成纤维细胞(CAFs)是肿瘤微环境(TME)的关键组成部分,会显著影响PCSC的干性。此外,CAFs通过释放信号分子和改变周围环境来促进PCSC的生长和存活。相反,PCSCs可能通过产生各种分子来影响CAFs的特征和行为。这种相互作用机制可能对前列腺癌的进展和治疗耐药性的产生至关重要。利用类器官对TME进行建模能够深入研究CAF-PCSC相互作用,为准确评估潜在靶基因和设计前列腺癌新治疗策略提供了有价值的临床前工具。本综述的目的是讨论目前关于CAF-PCSC相互作用和串扰背后的多层次多靶点调控机制的研究,旨在为应对前列腺癌治疗挑战的治疗方法提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0312/11291335/a2626214e01f/fcell-12-1412337-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0312/11291335/847d9bc6c5d4/FCELL_fcell-2024-1412337_wc_abs.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0312/11291335/6fb158d6c518/fcell-12-1412337-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0312/11291335/a2626214e01f/fcell-12-1412337-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0312/11291335/847d9bc6c5d4/FCELL_fcell-2024-1412337_wc_abs.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0312/11291335/6fb158d6c518/fcell-12-1412337-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0312/11291335/a2626214e01f/fcell-12-1412337-g002.jpg

相似文献

1
Cancer-associated fibroblasts and prostate cancer stem cells: crosstalk mechanisms and implications for disease progression.癌症相关成纤维细胞与前列腺癌干细胞:相互作用机制及其对疾病进展的影响。
Front Cell Dev Biol. 2024 Jul 18;12:1412337. doi: 10.3389/fcell.2024.1412337. eCollection 2024.
2
Dissecting the functions of cancer-associated fibroblasts to therapeutically target head and neck cancer microenvironment.解析癌症相关成纤维细胞的功能以靶向治疗头颈部癌症微环境。
Biomed Pharmacother. 2023 May;161:114502. doi: 10.1016/j.biopha.2023.114502. Epub 2023 Mar 14.
3
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.肿瘤微环境中癌症相关成纤维细胞与免疫细胞的串扰:新发现与未来展望。
Mol Cancer. 2021 Oct 11;20(1):131. doi: 10.1186/s12943-021-01428-1.
4
Prostate cancer stem cells and their targeted therapies.前列腺癌干细胞及其靶向治疗
Front Cell Dev Biol. 2024 Aug 8;12:1410102. doi: 10.3389/fcell.2024.1410102. eCollection 2024.
5
Novel Therapeutic Targets and Biomarkers Associated with Prostate Cancer-Associated Fibroblasts (CAFs).与前列腺癌相关成纤维细胞(CAFs)相关的新型治疗靶点和生物标志物。
Crit Rev Oncog. 2022;27(1):1-24. doi: 10.1615/CritRevOncog.2022043478.
6
Cancer-associated fibroblasts: The chief architect in the tumor microenvironment.癌症相关成纤维细胞:肿瘤微环境中的总设计师。
Front Cell Dev Biol. 2023 Jan 30;11:1089068. doi: 10.3389/fcell.2023.1089068. eCollection 2023.
7
Therapeutic targeting of the crosstalk between cancer-associated fibroblasts and cancer stem cells.针对癌症相关成纤维细胞与癌症干细胞之间相互作用的治疗靶点
Am J Cancer Res. 2019 Sep 1;9(9):1889-1904. eCollection 2019.
8
Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.肿瘤微环境中癌症相关成纤维细胞和免疫细胞的代谢重编程及串扰。
Front Endocrinol (Lausanne). 2022 Aug 15;13:988295. doi: 10.3389/fendo.2022.988295. eCollection 2022.
9
Cancer-Associated Fibroblast Heterogeneity, Activation and Function: Implications for Prostate Cancer.癌症相关成纤维细胞的异质性、激活与功能:对前列腺癌的影响。
Biomolecules. 2022 Dec 29;13(1):67. doi: 10.3390/biom13010067.
10
Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer.单细胞和批量 RNA 测序揭示了前列腺癌中与癌症相关的成纤维细胞异质性和预后特征。
Medicine (Baltimore). 2023 Aug 11;102(32):e34611. doi: 10.1097/MD.0000000000034611.

引用本文的文献

1
Cancer-Associated Fibroblasts: Immunosuppressive Crosstalk with Tumor-Infiltrating Immune Cells and Implications for Therapeutic Resistance.癌症相关成纤维细胞:与肿瘤浸润免疫细胞的免疫抑制性串扰及其对治疗耐药性的影响
Cancers (Basel). 2025 Jul 28;17(15):2484. doi: 10.3390/cancers17152484.
2
Cancer stem cells: landscape, challenges and emerging therapeutic innovations.癌症干细胞:现状、挑战与新兴治疗创新
Signal Transduct Target Ther. 2025 Aug 5;10(1):248. doi: 10.1038/s41392-025-02360-2.
3
CAF-mediated regulation of prostate cancer stem cell stemness via the Wnt/β-catenin and SDF-1/CXCR4 pathways in castration-resistant prostate cancer.

本文引用的文献

1
Repositioning of antiarrhythmics for prostate cancer treatment: a novel strategy to reprogram cancer-associated fibroblasts towards a tumor-suppressive phenotype.将抗心律失常药物重新定位用于前列腺癌治疗:一种向肿瘤抑制表型重编程癌相关成纤维细胞的新策略。
J Exp Clin Cancer Res. 2024 Jun 11;43(1):161. doi: 10.1186/s13046-024-03081-0.
2
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer.EAU-EANM-ESTRO-ESUR-ISUP-SIOG 前列腺癌诊治指南。第二部分-2024 年更新:复发性和转移性前列腺癌的治疗。
Eur Urol. 2024 Aug;86(2):164-182. doi: 10.1016/j.eururo.2024.04.010. Epub 2024 Apr 29.
3
在去势抵抗性前列腺癌中,癌相关成纤维细胞通过Wnt/β-连环蛋白和SDF-1/CXCR4途径对前列腺癌干细胞干性的调节
Front Cell Dev Biol. 2025 Jul 15;13:1617200. doi: 10.3389/fcell.2025.1617200. eCollection 2025.
4
Advancing prostate cancer research: an exploration of periprostatic adipose stem cells.推进前列腺癌研究:前列腺周围脂肪干细胞的探索
J Transl Med. 2025 Jul 14;23(1):794. doi: 10.1186/s12967-025-06734-6.
5
CAF-derived exosomal miR-196b-5p after androgen deprivation therapy promotes epithelial-mesenchymal transition in prostate cancer cells through HOXC8/NF-κB signaling pathway.雄激素剥夺治疗后,癌相关成纤维细胞衍生的外泌体miR-196b-5p通过HOXC8/NF-κB信号通路促进前列腺癌细胞的上皮-间质转化。
Biol Direct. 2025 Jul 4;20(1):80. doi: 10.1186/s13062-025-00667-2.
6
Protein-based Radiopharmaceuticals that target fibroblast activation protein alpha: a review of current progress.靶向成纤维细胞活化蛋白α的基于蛋白质的放射性药物:当前进展综述
EJNMMI Radiopharm Chem. 2025 Jun 21;10(1):32. doi: 10.1186/s41181-025-00356-5.
7
Multifaceted roles of OCT4 in tumor microenvironment: biology and therapeutic implications.OCT4在肿瘤微环境中的多方面作用:生物学及治疗意义
Oncogene. 2025 May;44(18):1213-1229. doi: 10.1038/s41388-025-03408-x. Epub 2025 Apr 14.
8
Colorectal carcinoma organoid and cancer-associated fibroblasts co-culture system for drug evaluation.用于药物评估的结直肠癌类器官与癌症相关成纤维细胞共培养系统
In Vitro Model. 2025 Mar 5;4(1):31-44. doi: 10.1007/s44164-025-00084-9. eCollection 2025 Feb.
9
Comprehensive analysis of the multifaceted role of ITGAV in digestive system cancer progression and immune infiltration.整合素αV(ITGAV)在消化系统癌症进展和免疫浸润中的多方面作用的综合分析。
Front Immunol. 2025 Feb 13;16:1480771. doi: 10.3389/fimmu.2025.1480771. eCollection 2025.
10
Androgen receptor dynamics in prostate cancer: from disease progression to treatment resistance.前列腺癌中的雄激素受体动态变化:从疾病进展到治疗抵抗
Front Oncol. 2025 Feb 11;15:1542811. doi: 10.3389/fonc.2025.1542811. eCollection 2025.
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
4
Integration Analysis of Single-Cell Multi-Omics Reveals Prostate Cancer Heterogeneity.单细胞多组学整合分析揭示前列腺癌异质性。
Adv Sci (Weinh). 2024 May;11(18):e2305724. doi: 10.1002/advs.202305724. Epub 2024 Mar 14.
5
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
6
Cancer stem cells and their niche in cancer progression and therapy.癌症干细胞及其微环境在癌症进展与治疗中的作用
Cancer Cell Int. 2023 Dec 1;23(1):305. doi: 10.1186/s12935-023-03130-2.
7
Cancer Stem Cells and Androgen Receptor Signaling: Partners in Disease Progression.癌症干细胞与雄激素受体信号:疾病进展中的伙伴。
Int J Mol Sci. 2023 Oct 11;24(20):15085. doi: 10.3390/ijms242015085.
8
Tumor Microenvironment: A Niche for Cancer Stem Cell Immunotherapy.肿瘤微环境:癌症干细胞免疫治疗的龛位。
Stem Cell Rev Rep. 2024 Jan;20(1):3-24. doi: 10.1007/s12015-023-10639-6. Epub 2023 Oct 20.
9
Prostate Cancer Stem Cells: Biology and Treatment Implications.前列腺癌干细胞:生物学和治疗意义。
Int J Mol Sci. 2023 Oct 4;24(19):14890. doi: 10.3390/ijms241914890.
10
The efficacy of natural bioactive compounds against prostate cancer: Molecular targets and synergistic activities.天然生物活性化合物抗前列腺癌的功效:分子靶点与协同活性
Phytother Res. 2023 Dec;37(12):5724-5754. doi: 10.1002/ptr.8017. Epub 2023 Oct 2.